| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
CSK |
CSK: Tyrosine-protein kinase CSK |
11.660 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
11.660 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
11.660 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
11.660 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
11.660 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
11.660 |
Evidence |
|
| VIL2 |
IPI00479359 |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
11.660 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
NEK8 |
NEK8, JCK, NEK12A: Serine/threonine-protein kinase Nek8 |
11.660 |
Evidence |
|
| PTPRF |
PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
11.660 |
Evidence |
|
| PTPRF |
PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
11.660 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
11.660 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
TGFBR2 |
TGFBR2: TGF-beta receptor type-2 precursor |
11.660 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
11.660 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
11.660 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
NEK8 |
NEK8, JCK, NEK12A: Serine/threonine-protein kinase Nek8 |
11.660 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
11.660 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
DOK1 |
DOK1: Docking protein 1 |
11.660 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
11.660 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
11.660 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
11.660 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
CAPN2 |
CAPN2, CANPL2: Calpain-2 catalytic subunit precursor |
11.660 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
11.660 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
11.660 |
Evidence |
|
| RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
11.660 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
SEMA5A |
SEMA5A, SEMAF: Semaphorin-5A precursor |
11.660 |
Evidence |
|